Synthetic Biologics, a company focused on microbiome research, presented two posters at Digestive Disease Week this year. The first poster summarizes preclinical data supporting the ability of SYN-004 ...
Denver, CO, April 16, 2026 (GLOBE NEWSWIRE)-- Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade” or the "Company”), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral ...
SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the presentation of two posters related to the company’s Targeted ...
GUILFORD, Conn., March 17, 2022 (GLOBE NEWSWIRE) -- Invea Therapeutics, Inc., a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results